| Title: | Testosterone derivative | ||
| Application Number: | 99807517 | Application Date: | 1999.06.14 |
| Publication Number: | 1305488 | Publication Date: | 2001.07.25 |
| Approval Pub. Date: | 2004.10.27 | Granted Pub. Date: | 2004.10.27 |
| International Classifi-cation: | A61K31/565;C07J1/00 | ||
| Applicant(s) Name: | Akzo Nobel N.V. | Address: | |
| Inventor(s) Name: | D. Leysen;H.A.A. Van Der Voort | ||
| Attorney & Agent: | tang weijie | ||
|
|
|
||
Abstract: |
|||
| The invention is the novel androgen (7alpha,17beta)-7-methyl-17-[(1-oxoundecyl)oxy]estr-4en-3one (MENT undecanoate). This compound distinguishes favourably from other testosterone derivatives in that it has a good solubility in oily media. It particularly exhibits a good dissolved potency relative to testosterone. The compound is particularly suitable for administration by means of injection. | |||
|
|
|||
| Time: | 4 | ||
<- Previous Patent:17 Beta-amino and hydroxylamino-1...
| Next Patent:Meiosis regulating compound ->
|
|||